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Smoking is the most signifi cant avoidable cause of morbidity, 
disability, and premature mortality in developed countries, so 
reduction of cigarette smoking continues to be one of the highest 
public health priorities (American Cancer Society, 2016; U. S. 
Department of Health and Human Services [USDHHS], 2014). 
Despite the serious health consequences, and the fact that the 
majority of people know the risks, smoking cessation is diffi cult 
to achieve, as is continuous abstinence for the majority of those 
who try to give up the habit (Brandon, Vidrine, & Litvin, 2007; 
Hughes, Keely, & Naud, 2004; Piasecki, 2006). Therefore, as also 
occurs in other addictive behaviours, a large number of those 
who achieve abstinence end up relapsing quite soon after quitting 
(Hajek, Stead, West, Jarvis, & Lancaster, 2013). Although most 
relapses occur during the fi rst month after quitting, after this 
period, their incidence decreases but they never cease to occur 
(Piñeiro & Becoña, 2013), even after several years (Míguez & 
Becoña, 2008). This implies that most smokers will require several 
attempts to quit before consolidating their abstinence (Brandon et 
al., 2007). 
Several studies have pointed out the multiple effects of tobacco 
use on health, as well as the benefi ts of smoking cessation (Centers 
for Disease Control and Prevention, 2008; Mons et al., 2015; 
USDHHS, 2014).  In contrast, knowledge about how smoking 
affects other aspects of health status like health-related quality 
of life (HRQoL), a relevant measure to study the health of the 
population (Herdman, 2000), is scarce. 
Despite the fact that a reduction in HRQoL among smokers 
has been found in different studies across populations of diverse 
socioeconomic and cultural groups  (e.g., Becoña et al., 2013; De 
Miguel et al., 2010; Mulder, Tijhuis, Smit, & Kromhout, 2001; 
Sarna, Bialous, Cooley, Jun, & Feskanich, 2008; Vogl, Wenig, 
Leidl, & Pokhrel, 2012), fi ndings across the studies are inconsistent. 
Whereas some studies have found strong associations for  general 
 ISSN 0214 - 9915 CODEN PSOTEG
Copyright © 2018 Psicothema
www.psicothema.com
Health-related quality of life among smoking relapsers
M. Carmen Míguez1, Ana López-Durán1, Carmela Martínez-Vispo1, Elena Fernández del Río2, Úrsula Martínez1,
Rubén Rodríguez-Cano1, and Elisardo Becoña1
1 Universidade de Santiago de Compostela and 2 Universidad de Zaragoza
Abstract Resumen
Background: Previous studies have shown that smoking is associated 
with health-related quality of life (HRQoL) impairment. In order to 
evaluate HRQoL in a sample of Spanish relapsers, a cross-sectional study 
was conducted. Method: The sample was made up of 775 smokers who 
had relapsed after a period of abstinence. HRQoL was evaluated using 
the Euro-Qol questionnaire (EQ-5D); through the descriptive profi le, 
the EQ-5D index and the visual analogue scale (EQ-VAS). Results: 
Higher nicotine dependence was related to worse HRQL. According to 
the EQ-VAS, higher daily cigarette consumption and more years smoking 
were related to worse perceived health. In the EQ-5D those who had 
quit smoking in the previous year perceived worse health. Mobility and 
anxiety / depression are the dimensions affected by smoking. Those 
who are more nicotine dependent (OR = 2.29) and have been smoking 
for longer (OR = 4.12) are more likely to have mobility problems; and 
those who are nicotine dependent (OR = 1.85) and relapsed more than a 
year ago (OR = 0.63), are more likely to experience anxiety / depression. 
Conclusions: Nicotine dependence demonstrated a determining effect on 
HRQOL deterioration in smokers who have relapsed.
Keywords: Health-related quality of life (HRQoL), smoking, relapse.
La calidad de vida relacionada con la salud en fumadores que han 
recaído. Antecedentes: estudios previos demuestran que fumar produce 
un deterioro de la calidad de vida relacionada con la salud (CVRS). Para 
evaluar la CVRS en fumadores españoles que han recaído se realizó 
un estudio transversal. Método: la muestra estaba formada por 775 
fumadores que habían recaído tras un período de abstinencia. La CVRS 
se evaluó mediante el cuestionario Euro-Qol 5D (EQ-5D), utilizando el 
perfi l descriptivo, el índice EQ-5D y la escala visual-analógica (EQ-EVA). 
Resultados: a mayor dependencia de la nicotina  peor CVRS. En la EQ-
EVA, a mayor consumo diario de cigarrillos y más años consumiendo, 
peor estado de salud percibido. En el EQ-5D los que dejaron de fumar 
en el último año son los que perciben peor estado de salud. Movilidad 
y ansiedad/depresión son las dimensiones afectadas en esta muestra de 
fumadores que han recaído. Es más probable que tengan problemas en 
movilidad los que tienen dependencia (OR = 2,29) y llevan más años 
fumando (OR = 4,12), y es más probable que presenten ansiedad/depresión 
los dependientes (OR = 1,85) y los que recayeron hace más de un año (OR 
= 0,63). Conclusiones: la dependencia de la nicotina mostró un efecto 
determinante en el deterioro de la CVRS en fumadores que han recaído.
Palabras clave: calidad de vida relacionada con la salud (CVRS), fumar, 
recaída.
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health and/or mental dimensions (Becoña et al., 2013; Guimaraes 
et al., 2011; Mulder et al., 2001; Schmitz, Kruse, & Kugler, 2003); 
no differences in HRQoL between smokers and non-smokers has 
also been observed (Bellido-Casado et al., 2004; Funahashi et al., 
2011). The different selection criteria and sample characteristics, 
as well as the instruments used to assess quality of life, could be 
partly responsible for these differences. 
Moreover, the effect of tobacco on smokers’ HRQoL may vary 
as a function of different smoking-related variables (e. g., number 
of cigarettes smoked, nicotine dependence). For instance, heavy 
smokers show lower HRQoL scores (Mulder et al., 2001; Sarna et 
al., 2008; Wilson, Chittleborough, Kirke, Grant, & Ruffi n, 2004). 
Davila et al. (2011) and Schmitz et al. (2003) found that dependent 
smokers reported poorer quality of life than non-dependent 
smokers.  Other variables studied to a lesser degree are age of 
regular smoking initiation, age at which smokers quit smoking, 
stages of change, and quit attempts. Bass, Wilson, and Griffi th 
(2004) found that smokers who initiate smoking before the age 
of 15 have lower HRQoL, and Gasperini et al. (2016) pointed out 
that a higher age at which smokers quit smoking is associated with 
lower scores in HRQoL. Grau, Font-Mayolas, Gras, Suñer, and 
Noguera (2007) found that smokers who were in stages of change 
close to quitting smoking indicated worse perceived physical 
health, and smokers who had no intention of quitting presented 
worse mental health.  Finally, McClave, Dube, Strine, and Mokdad 
(2009) indicated that certain HRQoL characteristics were worse 
among smokers who unsuccessfully attempted to quit. They also 
found better HRQoL among former smokers than among smokers 
who did not made quit attempts.Therefore, studies indicate 
than non-smokers have better HRQoL than smokers, and that 
former smokers have better HRQoL than people who continued 
smoking. What has not been evaluated yet is how it affected the 
HRQoL of smokers who made attempts to quit smoking, achieved 
abstinence for some time and, fi nally, relapsed. We considered that 
this research may involve progress in both research and clinical 
practice, because relapse is common during the process of giving 
up smoking, and HRQoL is an important motivational variable to 
stop smoking.
In view of the above, we carried out the current research to 
identify HRQoL impairment among a sample of Spanish smokers 
from the general population who had relapsed in the past 5 years. 
To our knowledge, this is the fi rst study to examine HRQoL in 
this population. Therefore, the aim of this study was, fi rstly, to 
describe HRQoL in relapsers from general population. Secondly, 
to identify the variables that are related to HRQoL impairment, 
both at the general level and in the different dimensions, that is, 
the profi le of the relapsers presenting a worse HRQoL. 
Method
Participants
The sample was made up of 775 daily smokers, 363 men (46.8%) 
and 412 (53.2%) women, from the general Spanish population. 
Participants were recruited according to the following criteria: 
(1) having smoked in the last 10 years for at least one year daily 
and uninterruptedly; (2) smoking at least 10 cigarettes per day; 
(3) having quit smoking in the last 5 years for at least one month 
uninterruptedly and having relapsed; and (4) at the time of the 
assessment, smoking at least one month since the relapse. 
Procedure
A cross-sectional study was performed in which data were 
collected anonymously from 1017 smokers from the general 
population by means of an ad hoc questionnaire.  The questionnaires 
of 242 participants were eliminated due to incomplete data. 
Participants were recruited through “snowball” method. 
Instruments
A self-administered questionnaire about sociodemographics 
(age, gender, marital status, education, and employment status) 
and smoking-related variables was used in this study. Participants 
answered questions about number of cigarettes smoked per 
day, number of years smoking, quit attempts in the last 5 years, 
days without smoking, relapses, stages of change, and nicotine 
dependence. The degree of motivation to give up smoking was 
assessed with the Stages of Change Questionnaire (Prochaska, 
DiClemente, & Norcross, 1992). For the assessment of nicotine 
dependence, we used the Fagerström Test for Nicotine Dependence 
(FTND; Heatherton, Kozlowski, Frecker, & Fagerström, 1991; 
Spanish version of Becoña & Vázquez, 1998), a six-item scale 
with scores ranging from 0 to 10. A score of 6 or more indicates 
nicotine dependence. 
Data on the HRQoL were obtained using the EuroQoL Group 
Health Questionnaire (EQ-5D; EuroQoL Group, 1990; Spanish 
adaptation of Badia, Roset, Montserrat, Herdman, & Segura, 1999). 
This generic measurement instrument of HRQoL consists of two 
parts. The fi rst provides descriptive information about fi ve health 
dimensions: mobility, self-care, usual activities (work, studies, 
household tasks), pain/discomfort and anxiety/depression. For 
each dimension, individuals choose the level of severity, among 
three possibilities, that best refl ects their health status on the day 
they fi ll in the questionnaire; each health status is assigned a single 
value (tariff) using a standardized formula anchored on a scale 
ranging from 0 (being dead) and 1 ( full health) (EQ-5D Index). 
The second part of the EQ-5D is a Visual Analogue Scale 
(VAS) ranging from 0 (worst health status imaginable) to 100 
(best health status imaginable). Respondents indicate on the 
scale the point that best represents their global health status on 
the assessment day. The VAS provides quantitative information 
about the global health status perceived by the individual, 
complementary to the descriptive system of the self-assessment of 
health status by dimensions. 
Average completion time of the questionnaires was 10 
minutes.
Data analysis 
All analyses were conducted with SPSS version 20.0, with a 
p-value of < .05 considered signifi cant. A descriptive statistics 
analysis was made of the total sample (N = 775) to analyze the 
sociodemographic and tobacco consumption characteristics. We 
used chi-square test to analyze differences between respondent 
categories in the EQ-5D profi le data, and t-tests to analyze the EQ-
5D Index and VAS scores. Cramers’s V coeffi cients and Cohen’s d 
were calculated to estimate the effect size. 
We used linear regression to analyze the variables that 
predicted a worse perception of QoL on the EQ VAS and EQ-
5D. Age, number of cigarettes smoked at the evaluation moment, 
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total score in the Fageström test, number of years of consumption, 
and number of days of abstinence were introduced as independent 
variables. Moreover, to examine predictors of the presence of 
problems in each of the fi ve dimensions of the EQ-5D, binary 
logistic regression analyses with forward stepwise selection 
were performed. All signifi cant variables in bivariate analyses 
were introduced as independent variables: age (<50), sex, marital 
status (with partner / non-partner), education level (university / 
non-university), work situation number of cigarettes smoked at 
the evaluation  moment (<25), Fageström score (dependent / non-
dependent), years of consumption (<25), number of quit attempts 
within the last year (none / one or more), relapse time (last year / 
2 to 5 years), and the other quality of life dimensions (mobility, 
personal care, daily activities, pain and anxiety / depression). 
Results
Sociodemographic and tobacco consumption characteristics
Mean age of the sample is 42 years (SD = 10.83). Of them, 
53.2% are women, 58.6% are married or living with a partner, 
35.3% have university studies, and the majority (71.2%) are 
employees. 
Participants smoked an average of 15.60 cigarettes /day (SD = 
6.49, range 10 -60). They had been smoking an average of 23.85 
years (SD = 10.46), 29.9% smoked 20 or more cigarettes (heavy 
smokers), 16.8% presented nicotine dependence, and 50.2% were 
in the stage of contemplation. 
The average number of days they were abstinent, adding all 
their attempts, was 238 days (SD = 393.39). Considering the 
relapse moment, 37.5% had relapsed in the past year, and 62.5% 
more than one and less than fi ve years ago. 
Quality of life, sociodemographic and smoking-related variables
The percentage of individuals who reported some or severe 
problems on the EQ-5D domains varied: pain and discomfort 
(28.6%); anxiety and depression (23.7%); usual activity (8.8%); 
mobility (5.8%); and self-care (0.8%). There were signifi cant 
differences as a function of age in mobility, χ² (2, 775) = 12.91, 
p ≤ .005, V = 0.13, with people over 60 having more problems. 
Regarding gender, women (Table 1) reported more impairment 
than men in performance of usual activities, and more pain/
discomfort and anxiety/depression.
Regarding EQ-5D Index and VAS (Table 2), the mean EQ-5D 
index was 0.89 (SD = 0.15) and the mean VAS score was 75.91 
(SD = 15.36).  Respect to sociodemographic characteristics, 
signifi cantly lower scores in both index were obtained by gender 
(women), age (50 years old or more), marital status (divorced/
separated/widowed), education level (without university studies), 
and work situation (does not work). Respect to smoking related 
variables, it was found signifi cant differences in nicotine 
dependence and number of quit attempts within the last year in 
the mean EQ-5D index. Differences in mean VAS score were 
signifi cant in number cigarettes per day, nicotine dependence, and 
years of consumption.
Predictors of quality of life
The linear regressions show that nicotine dependence was the 
only one predictor of HRQoL, as measured with the EQ-5D index 
(R2 = 0.022) and the VAS (R2 = 0.059). Higher levels of dependence 
correspond to worse HRQoL.
Logistic regression analysis (Table 3) showed that mobility 
and anxiety/depression are affected by smoking-related variables. 
Specifi cally, nicotine dependence (OR = 2.29) and more years 
of consumption (OR = 4.12) increase the likelihood of having 
mobility problems. In addition, nicotine dependence (OR = 1.85) 
and having relapsed more than one year ago (OR = 0.63) increased 
the likelihood of presenting anxiety/depression.
 
Discussion
The aim of this study was to investigate self-perceived HRQoL in 
a sample of smokers with a relapse history. Taking into account the 
dimensions of the EQ-5D, the results showed that pain/discomfort 
and anxiety/depression are the dimensions in which participants 
presented more problems, especially in the case of women. 
Taking into account the mean score of the  EQ-5D index and 
the EQ VAS,  the sociodemographic profi le of the relapsers who 
present worse HRQoL is characterized as being female, being 
50 or older, lower educational level, being divorced/separated or 
Table 1
Percentage of reported problems by dimension and sex
Total Men Women
















































































14.727***   1.14
* p ≤ .05; *** p ≤ .001
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widowed, and not to work. Regarding smoking-related variables, 
nicotine dependence is the main variable associated with a worse 
HRQoL. Poor HRQoL on the EQ VAS is also related to more 
years of consumption and higher daily consumption. 
The high percentage of the presence of anxiety/depression 
coincides with studies that suggest  that smokers are more prone 
to suffer these symptoms than non-smokers (De Lossada & Rejas, 
2016; Schmitz et al., 2003). Likewise, it has been well-documented 
that the prevalence of smoking is extremely high in people who 
experience anxiety and depression (Dierker, Avenevoli, Stolar, & 
Merikangas, 2002; Fergusson, Goodwin, & Horwood, 2003).
One of the most important results of this study is that women 
have worse HRQoL than men, both in general index and in pain/
discomfort and anxiety/depression dimensions. Women that 
smoke are at higher risk of mortality due to lung cancer than never-
smokers or ex-smokers women (Pirie et al., 2013). In addition, 
women have other specifi c negative consequences because of 
smoking, such as reproductive problems, increased risk of cervix 
cancer and premature menopause (USDHHS, 2014). Moreover, 
the association between depressive disorders and smoking is 
more frequent among women (Husky et al., 2008), since they use 
it for mood management (Fidler & West, 2009) and have higher 
expectations of negative affect reduction due to smoke (Baker, 
Piper, McCarthy, Majeskie, & Fiore, 2004). Women may have 
greater diffi culties than men to quit (Perkins & Scott, 2008) and 
depressive symptoms could play a signifi cant role (Weinberger, 
Pilver, Desai, Mazure, & McKee, 2013). 
Regarding to smoking-related variables, a signifi cant dose-
response relationship between cigarette consumption and HRQoL 
was previously noted (e.g., Mulder et al., 2001; Vogl et al., 
2012), with progressively lower scores for smokers with higher 
consumption. This data may be indicating the existence of a strong 
dose-response relationship between cigarette consumption and 
severe diseases (Royal College of Physicians, 2007).
Respect to predictors of HRQoL, mobility and anxiety/
depression are affected by smoking-related variables. Nicotine 
dependence and more of years of consumption predict impairment 
in mobility. More smoking years and nicotine dependence are 
related to physical health deterioration (e.g., fatigue, respiratory 
problems) (Schmitz et al., 2003) which will signifi cantly affect 
the person mobility. Otherwise, nicotine dependence and having 
relapsed more than a year ago increase the likelihood of presenting 
anxiety / depression. This result is in line with previous studies 
that indicate the existence of greater nicotine dependence in 
people with mood problems (Weinberger et al., 2016) and, as in 
the investigation of Grau et al. (2007), smokers with worse mental 
health have lower intention of quitting. 
Although in this study we have explored the different smoking-
related variables that the literature has linked to HRQoL, 
nicotine dependence remains as the explanatory variable of 
anxiety/depression in the regression models. In previous studies, 
nicotine dependence was also related to impairment of the mental 
component of HRQoL (Becoña et al., 2013; Schmitz et al., 2003). 
As other authors have informed (Breslau, Killey, & Andreski, 
1993; Schmitz et al., 2003), these data could be partially attributed 
Table 2
Scores of EQ VAS and EQ-5D Index of smokers according to 
sociodemographic and smoking-related variables
  EQ VAS
M  (SD)
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Contemplation/Preparation  
(n = 456)
76.06  (15.55) 
75.80  (15.25)
-0.23 0.90  (0.14)
0.88  (0.15)
 -1.05
Quit attempts previous year
None (n = 435)
1 or more (n = 340)
75.65  (15.09)
76.25  (15.73)
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Table 3
Predictors of the dimensions of quality of life
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to the rates of psychiatric comorbidity (in particular, affective 
and anxiety disorders), which are higher in nicotine-dependent 
smokers than in non-dependent ones.
The variability of QoL measures used (Goldenberg, Danovitch, 
& IsHak, 2014) become diffi cult to make quantitative comparisons 
of the results due to the nature and content of the QoL instrument 
employed. Precisely, one of the challenges in QoL is the use of 
instruments with a universal defi nition of the construct that allows 
comparing the results at the international and cross-cultural levels 
(Benítez, 2016).  
An important contribution of this study is that it is focused on 
relapsers. Having suffered relapses can undermine the motivation 
to quit if it is experienced as a failure. However, relapse can also 
be seen as a learning experience to increase motivation, based on 
the notion that “I know that I can manage to quit smoking”. In 
fact, in our sample, we observed higher motivation to quit among 
those who have tried to quit smoking more recently because, out 
of those who were at preparation stage, 63.1% quit smoking in 
the past year. Previous studies (McClave et al., 2009) show that 
HRQoL was worse among smokers who unsuccessfully attempted 
to quit than among smokers who made no attempts to quit. 
Limitations in the present study indicate that our results should 
be interpreted with some caution. First, the cross-sectional design 
of the study does not allow establishing causal relations. Likewise, 
the sampling method used limits the representativeness of the 
sample and, therefore, the generalization of the results. In addition, 
information on tobacco consumption and HRQoL were based on 
self-report and not confi rmed by collateral informants. As a result, 
recall bias or tendency to provide socially acceptable responses 
(i.e., underestimation of consumption) is a potential limitation. 
Furthermore, no pre-relapse assessments were carried out, which 
does not allow us to know how relapses affected HRQoL. 
Despite these limitations, the strengths of this study are the large 
sample size of relapsers. Moreover, few studies have examined the 
association between smoking and HRQoL by means of the EQ-5D 
scores and, to our knowledge, this is the fi rst one that evaluates 
impairment of HRQoL in relapsers, providing information both at 
a global level and by dimensions.
In conclusion, the present study contributes to improving 
knowledge about association between smoking and HRQoL. 
Taking into account that the average smoker must make several 
quit attempts before achieving long-term abstinence (Hughes 
et al., 2004), more investigations are required about the impact 
of relapses. Future studies should provide comparative data on 
HRQoL among relapsers, smokers who unsuccessfully attempted 
to quit, and smokers who never tried to quit.
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